Price Transparency in United States' Health Care: A Narrative Policy Review of the Current State and Way Forward.

IF 1.7 4区 医学 Q3 HEALTH CARE SCIENCES & SERVICES
David N Bernstein, Jonathan R Crowe
{"title":"Price Transparency in United States' Health Care: A Narrative Policy Review of the Current State and Way Forward.","authors":"David N Bernstein, Jonathan R Crowe","doi":"10.1177/00469580241255823","DOIUrl":null,"url":null,"abstract":"<p><p>Health care price transparency is gaining momentum as a tangible policy intervention that can unleash market principles to increase competition, help begin to decrease U.S. health care expenditures, and provide Americans with access to affordable, high-quality health care. Indeed, pricing reform is required to facilitate patient shopping in health care. In this narrative policy review, we offer a brief history of health care price transparency efforts and an overview of the health care price transparency literature. Further, we highlight the current rules and legislative initiatives aimed at achieving the full potential of health care price transparency. Lastly, we offer key takeaways and highlight suggestions for future policy directions, including the need to ensure hospital and insurance compliance through more appropriate penalties and incentives, importance of reducing regulation to promote financial upside that can be obtained by both patients and providers who actively promote shopping for lower cost, higher quality health care goods and services, and the need for transparent and easily found quality metrics, including outcomes most important to patients, driven by physicians \"on the ground\" with patient input.</p>","PeriodicalId":54976,"journal":{"name":"Inquiry-The Journal of Health Care Organization Provision and Financing","volume":null,"pages":null},"PeriodicalIF":1.7000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11129567/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Inquiry-The Journal of Health Care Organization Provision and Financing","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/00469580241255823","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

Abstract

Health care price transparency is gaining momentum as a tangible policy intervention that can unleash market principles to increase competition, help begin to decrease U.S. health care expenditures, and provide Americans with access to affordable, high-quality health care. Indeed, pricing reform is required to facilitate patient shopping in health care. In this narrative policy review, we offer a brief history of health care price transparency efforts and an overview of the health care price transparency literature. Further, we highlight the current rules and legislative initiatives aimed at achieving the full potential of health care price transparency. Lastly, we offer key takeaways and highlight suggestions for future policy directions, including the need to ensure hospital and insurance compliance through more appropriate penalties and incentives, importance of reducing regulation to promote financial upside that can be obtained by both patients and providers who actively promote shopping for lower cost, higher quality health care goods and services, and the need for transparent and easily found quality metrics, including outcomes most important to patients, driven by physicians "on the ground" with patient input.

美国医疗保健的价格透明度:美国医疗保健中的价格透明:现状与前进方向的政策回顾》(A Narrative Policy Review of the Current State and Way Forward)。
医疗保健价格透明作为一项切实可行的政策干预措施,正在获得越来越多的关注,它可以释放市场原则以增加竞争,帮助开始减少美国的医疗保健支出,并为美国人提供负担得起的高质量医疗保健服务。事实上,定价改革是促进患者选择医疗服务的必要条件。在这篇叙述性政策回顾中,我们简要介绍了医疗价格透明化工作的历史,并概述了医疗价格透明化文献。此外,我们还强调了旨在充分发挥医疗价格透明度潜力的现行规则和立法倡议。最后,我们提出了一些重要启示,并强调了对未来政策方向的建议,包括需要通过更适当的惩罚和激励措施来确保医院和保险公司遵守规定;必须减少监管,以促进患者和医疗服务提供者获得经济上的好处,他们可以积极推动购买成本更低、质量更高的医疗产品和服务;需要透明且易于发现的质量指标,包括对患者最重要的结果,由 "在现场 "的医生根据患者的意见来推动。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.50
自引率
0.00%
发文量
192
审稿时长
>12 weeks
期刊介绍: INQUIRY is a peer-reviewed open access journal whose msision is to to improve health by sharing research spanning health care, including public health, health services, and health policy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信